Key facts
- Solas Capital Management, LLC filed SCHEDULE 13G/A for FENNEC PHARMACEUTICALS INC. Common Shares, no par value (FENC).
- Disclosed ownership: 7.2%.
- Date of event: 31 Mar 2026.
Solas Capital Management, LLC - 31 Mar 2026 SCHEDULE 13G/A Report for FENNEC PHARMACEUTICALS INC. Common Shares, no par value (FENC)
- Filing Manager
- Solas Capital Management, LLC
- Reporting Manager
- Solas Capital Management, LLC
- Symbol
- FENC
- Shares outstanding
- 34,474,972 shares
- Disclosed Ownership
- 2,482,198 shares
- Ownership
- 7.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2026, 10:58:37 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Key filing fact
Solas Capital Management, LLC disclosed 7.2% ownership in FENNEC PHARMACEUTICALS INC. Common Shares, no par value (FENC) on 31 Mar 2026.
Change
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 15 May 2026, 10:58.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Solas Capital Management, LLC | 7.2% | 2,482,198 | 0 | 2,482,198 | /s/ Frederick Tucker Golden | General Partner, Solas Capital Holdings, LP, its Member | |
| FREDERICK TUCKER GOLDEN | 7.2% | 2,482,198 | 0 | 2,482,198 | /s/ Frederick Tucker Golden | Frederick Tucker Golden |
CIK / CUSIP context first